Novel application of anti‐human Fc nanobody for screening high‐producing CHO cells for monoclonal antibody

Animal‐derived anti‐IgG secondary antibodies are currently employed to stain and screen of human monoclonal antibody(mAb)‐producing cells, but using animal‐derived antibodies may raise the concerns of high cost, complicated operations and biological safety issues in biopharmaceutical manufacturing....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Di, Wang, Zheng, Xu, Yunxia, Lin, Jing, Qiu, Mei, Liu, Jianghai, Li, Xinlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550735/
https://www.ncbi.nlm.nih.gov/pubmed/36247827
http://dx.doi.org/10.1002/elsc.202200028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550735/
https://www.ncbi.nlm.nih.gov/pubmed/36247827
http://dx.doi.org/10.1002/elsc.202200028

Ejemplares similares